ArticleClinical and experimental medicine2018

Kallikrein-related peptidase 6 (KLK6) expression differentiates tumor subtypes and predicts clinical outcome in breast cancer patients.

Christoforos Haritos et al.PubMed ↗Publisher ↗

No numbers read from the abstract.